Emtricitabine
Links shared publicly online about this topic
Complera (Rilpivirine + Emtricitabine + Tenofovir) - The Body
thebody.com — “What Is Complera? Complera is a tablet that contains three antiretroviral drugs (ARVs) used to fight HIV: rilpivirine (Edurant), emtricitabine (Emtriva), ...” View full resource at thebody.com
Most Recently Shared on September 5, 2011 at 7:00 pm By:
Fact Sheet on Complera (Rilpivirine + Emtricitabine + Tenofovir) http://t.co/rbQiwr8 #hiv #aids #antiretrovirals #medications
An Overview of Complera (Rilpivirine/Tenofovir/Emtricitabine) - The Body
thebody.com — “ef-FAH-ver-enz / em-tri-SIT-uh-bean / te-NOE-fo-veer” View full resource at thebody.com
Most Recently Shared on August 17, 2011 at 10:01 pm By:
An Overview of Complera (Rilpivirine/Tenofovir/Emtricitabine) http://t.co/4UjBvUf #hiv #aids #antiretrovirals #medications #combination
Approval of Complera: emtricitabine/rilpivirine/tenofovir DF fixed dose combination
fda.gov — “FDA approval of Approval of Complera, a new emtricitabine/rilpivirine/tenofovir DFfixed dose combination product for treatment of HIV” View full resource at fda.gov
Most Recently Shared on August 11, 2011 at 3:02 pm By:
Trish D'Antonio Health Professional
HIV and AIDS Activities Approval of Complera: emtricitabine/rilpivirine/tenofovir DF fixed dose combination: http://t.co/BVRnb2W
IngentaConnect Efavirenz/emtricitabine/tenofovir: Immune reconstitution syndrome...
ingentaconnect.com — “IngentaConnect Efavirenz/emtricitabine/tenofovir: Immune reconstitution syndrome...” View full resource at ingentaconnect.com
Most Recently Shared on July 4, 2010 at 2:05 pm By:
Efavirenz/emtricitabine/tenofovir: Immune reconstitution syndrome associated with Pneumocystis carinii pneumonia: ... http://bit.ly/dyozu3
HCV New Drug Research: HIV Prophylaxis; CDC Offers Guidance for Use of Emtricitabine plus Tenofovir
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: HIV Prophylaxis; CDC Offers Guidance for Use of Emtricitabine plus Tenofovir” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on January 31, 2011 at 4:14 am By:
Tina Banwart - HepatitisCNewDrugs Health Blog
HIV Prophylaxis; CDC Offers Guidance for Use of Emtricitabine plus Tenofovir http://goo.gl/fb/Xc1HR
Medical News: Female HIV Prevention Trial Halted - in HIV/AIDS, HIV/AIDS from MedPage Today
medpagetoday.com — “The so-called FEM-PrEP trial of emtricitabine and tenofovir disoproxil fumarate for preventing HIV infection in at-risk women will be stopped after an interim review indicated that its effectiveness w” View full resource at medpagetoday.com
Most Recently Shared on April 18, 2011 at 6:36 pm By:
Female HIV prevention trial halted: http://bit.ly/ft1KoP
Forum on Choosing Your Meds: Truvada (tenofovir) And Kidneys
thebody.com — “Ask the experts your questions on HIV and AIDS treatment at The Body, the AIDS Authority. Got questions on starting treatment? Want to ask a question about stopping treatment? This is the place to get your questions answered!” View full resource at thebody.com
Most Recently Shared on October 15, 2010 at 3:03 pm By:
Ask the HIV/AIDS Experts: "Is Truvada Truly Dangerous for HIVers' Kidneys?" http://bit.ly/d4PgUh #tenofovir #emtricitabine
Daily Tablet Protects Uninfected High Risk Gay Men From HIV Infection
medicalnewstoday.com — “A single daily tablet was found to lower HIV risk by 43.8% to 72.8% among high risk uninfected individuals. The tablet, brand name Truvada, contains emtricitabine and tenofovir (FTC/TDF), two comm” View full resource at medicalnewstoday.com
Most Recently Shared on November 23, 2010 at 7:13 pm By:
Daily Tablet Protects Uninfected High Risk Gay Men From HIV Infection http://mnt.to/3N6b #healthnews
HIV drug gives hope for prevention - USATODAY.com
usatoday.com — “A major study shows for the first time that a drug duo widely used to treat the AIDS virus can block HIV infection, researchers said Tuesday.” View full resource at usatoday.com
Most Recently Shared on November 23, 2010 at 3:37 pm By:
krupali tejura, m.d. Oncologist, Radiation Oncologist, Physician, and Doctor
New HIV drug gives hope for prevention http://usat.me?41305494
Gilead Submits New Drug Application to U.S. FDA for Once-Daily, Single-Tablet "Quad" HIV Regimen
drugs.com — “Quad HIV Regimen (cobicistat, elvitegravir, emtricitabine and tenofovir) is a new drug combinaton in development for the treatment of HIV infection. Quad HIV Regimen information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on October 31, 2011 at 2:17 am By:
Drugs and Devices OW OW Health
Gilead Submits New Drug Application to U.S. FDA for Once-Daily, Single-Tablet "Quad" HIV Regimen: FOSTER C... http://t.co/zuS71OJg #drug
Pills Prevent H.I.V. Infection in 2 New Studies - NYTimes.com
nytimes.com — “Trials conducted in Africa were the first to show protection in heterosexuals whose partners had H.I.V.” View full resource at nytimes.com
Most Recently Shared on July 14, 2011 at 12:00 am By:
Colin Son Doctor, Medical Student, and Physician
Tenofovir and emtricitabine help prevent the transmission of HIV http://t.co/E4iEjdq
Medical News: HIV Drug Combos Not Equal at High Viral Loads - in HIV/AIDS, HIV/AIDS from MedPage Today
medpagetoday.com — “In patients with a high HIV viral load at the start of initial therapy, regimens based on tenofovir/emtricitabine (Truvada) were more effective than those based on abacavir/lamivudine (Epzicom), resea” View full resource at medpagetoday.com
Most Recently Shared on December 1, 2009 at 6:49 pm By:
HIV Drug Combos Not Equal at High Viral Loads (CME/CE) http://ow.ly/165Lff
Medical News: Female HIV Prevention Trial Halted - in HIV/AIDS, HIV/AIDS from MedPage Today
medpagetoday.com — “The so-called FEM-PrEP trial of emtricitabine and tenofovir disoproxil fumarate for preventing HIV infection in at-risk women will be stopped after an interim review indicated that its effectiveness w” View full resource at medpagetoday.com
Most Recently Shared on April 18, 2011 at 6:22 pm By:
Female HIV Prevention Trial Halted http://bit.ly/gGSjYS
Once Daily Pill Shows Promising Results In Preventing Heterosexual HIV Transmission
medicalnewstoday.com — “Now the risk of acquiring HIV by people who are HIV negative can be reduced by as much as 73% by taking a daily dose of tenofovir or tenovofir/emtricitabine. These antiretroviral tablets can be ta” View full resource at medicalnewstoday.com
Most Recently Shared on July 14, 2011 at 10:05 pm By:
Once Daily Pill Shows Promising Results In Preventing Heterosexual HIV Transmission http://mnt.to/3YgB #hivaids
Experimental Quad Regimen For HIV-1 Naïve Patients Meets Primary Endpoint In Trial
medicalnewstoday.com — “A Phase III clinical trial of Quad regimen including elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate for treatment naïve HIV-1 patients met its primary endpoint” View full resource at medicalnewstoday.com
Most Recently Shared on August 15, 2011 at 8:05 pm By:
Experimental Quad Regimen For HIV-1 Naïve Patients Meets Primary Endpoint In Trial http://mnt.to/3YXb #hivaids
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
The Body
The Complete HIV/AIDS Resource.
-
The Body
The Complete HIV/AIDS Resource.
-
Trish D'Antonio
board certified geriatric pharmacist, senior care pharmacist, pharmacist continuous professional development, consultant pharmacist, DC Board of Pharmacy
Advertisement
